However, it is important to recognize that ongoing use is typically required to maintain these benefits
GLP-1 receptor agonists such as liraglutide, semaglutide, and dulaglutide have shown significant reductions in major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke, primarily in people with established cardiovascular disease or high cardiovascular risk
Researchers analyzed 28 studies and found that NAC significantly reduced MDA (a marker of oxidative stress), IL-8, and homocysteine levels, which are linked to inflammation
The peptide is not found naturally in the human body
Clear solution is expected after gentle mixing